DUAL ANTIPLATELET THERAPY OR APIXABAN IN PATIENTS...

DUAL ANTIPLATELET THERAPY OR APIXABAN IN PATIENTS INELIGIBLE FOR VITAMIN-K ANTAGONISTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: LESSONS FROM THE RECENT ASPIRIN-CONTROLLED TRIALS

Jeroen Jaspers Focks, Marc A. Brouwer, Freek W.A. Verheugt
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
57
Year:
2011
Language:
english
DOI:
10.1016/s0735-1097(11)60061-2
File:
PDF, 193 KB
english, 2011
Conversion to is in progress
Conversion to is failed